Comparing opioid-free and opioid-based anesthesia for breast reconstruction surgery
Official title: Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.
Run by Institut Curie · NCT05439005 · Data updated 2026-11-12
This study is testing whether using an opioid-free anesthesia during breast reconstruction surgery can help women manage pain and recover better compared to traditional opioid-based anesthesia.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 158 (estimated) |
| Sponsor | Institut Curie Academic / other |
| Locations | 3 sites (Paris and 2 other locations) |
| Status | Recruiting |
| Started | December 7, 2022 |
| Main results expected | June 6, 2027 |
| Study ends | June 6, 2027 |
| Registry record updated | January 30, 2026 |
| Trial ID | NCT05439005 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 18 or older who are eligible for free flap reconstruction surgery and have French health insurance.
✕Probably not a fit
Patients with allergies to the study medications or those with significant cardiovascular or respiratory conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the consumption of morphine in patients undergoing free flap reconstruction surgery of the breast, using either opioid-free anesthesia or conventional opioid-based anesthesia. It is a Phase III multicentric randomized controlled trial that will assess postoperative pain management and recovery outcomes. The primary focus is on the first 48 hours after surgery, evaluating the effectiveness of dexmedetomidine as an alternative to opioids. The study will involve women aged 18 and older who meet specific eligibility criteria.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management and reduced opioid use in breast reconstruction surgery patients.
How similar studies have gone: Other studies have shown promising results with opioid-sparing techniques in surgical settings, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Women aged 18 or older. 2. Patients with a French health insurance coverage (having a French social security number). 3. Patient eligible for free flap reconstruction surgery of the breastunder general anaesthesia. 4. Patient who has given written consent to participate in accordance with the regulations. 5. Having a negative blood pregnancy test for patients of childbea ring age. Exclusion Criteria: 1. Allergy or intolerance to any of the drugs (dexmedetomidine, remifentanil, lidocaine, propofol, dexamethasone, kétamine, ketoprofen, nefopam, paracetamol, morphine, ropivacaine, droperidol, ondansetron). 2. Known history of heart failure, arrhythmias and/or ischemic heart disease and/or severe renal insufficiency. 3. Pulse below 50bpm during anaesthesia consultation and/or under beta blocker treatment. 4. Treatment with ACEI/ARB. 5. Severe asthma. 6. Symptomatic gastric or duodenal ulcer with or without treatment. 7. Baseline systolic blood pressure \< 100 mmHg. 8. Chronic preoperative pain and/or use of WHO ladder step 2 or 3 analgesics preoperatively. 9. Patient already included in another therapeutic trial evaluating an experimental molecule. 10. Persons deprived of liberty or under guardianship. 11. Patients with suspected difficulties in assessing pain on a scale. 12. Inability to undergo trial medical monitoring due to geographic, social or psychological reasons.
Where it's running
-
Institut Curie Paris
Paris, France Recruiting -
Institut Curie Saint-Cloud
Saint-Cloud, France Recruiting -
Gustave Roussy, Cancer Campus, Grand Paris
Villejuif, France Recruiting
Study contacts
- Study coordinator: Anne-Claire COYNE, PhD
- Email: anne-claire.coyne@curie.fr
- Phone: 0033156245765
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.